Resveratrol enhances the effects of ALA-PDT on skin squamous cells A431 through p38/ MAPK signaling pathway
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resveratrol enhances the effects of ALA-PDT on skin squamous cells A431 through p38/ MAPK signaling pathway
Authors
Keywords
-
Journal
Cancer Biomarkers
Volume 21, Issue 4, Pages 797-803
Publisher
IOS Press
Online
2017-12-30
DOI
10.3233/cbm-170495
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- P3.03-002 Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations
- (2017) T. Yamada et al. Journal of Thoracic Oncology
- Anticancer Effects of Resveratrol-Loaded Solid Lipid Nanoparticles on Human Breast Cancer Cells
- (2017) Wenrui Wang et al. MOLECULES
- Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review
- (2016) Giovana Calixto et al. MOLECULES
- Photodynamic Therapy for Non-Melanoma Skin Cancers
- (2016) Diana Cohen et al. Cancers
- Downregulation of Survivin by shRNA Inhibits Invasion and Enhances the Radiosensitivity of Laryngeal Squamous Cell Carcinoma
- (2015) Jiang Hu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer
- (2015) Silvia Lucena et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Resveratrol and cancer: focus on in vivo evidence
- (2014) Lindsay G Carter et al. ENDOCRINE-RELATED CANCER
- The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma-implications on the T-classification system
- (2014) Nicholas D.L. Brougham et al. JOURNAL OF SURGICAL ONCOLOGY
- Efficacy of topical ALA-PDT combined with excision in the treatment of skin malignant tumor
- (2014) Yuan-gang Lu et al. Photodiagnosis and Photodynamic Therapy
- Photodynamic Therapy for Treatment of Solid Tumors — Potential and Technical Challenges
- (2014) Zheng Huang et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- The inhibition of resveratrol to human skin squamous cell carcinoma A431 xenografts in nude mice
- (2013) Yuqin Hao et al. FITOTERAPIA
- Trimethoxy-Resveratrol and Piceatannol Administered Orally Suppress and Inhibit Tumor Formation and Growth in Prostate Cancer Xenografts
- (2013) Steven J. Dias et al. PROSTATE
- Platycodin D induces anoikis and caspase-mediated apoptosis via p38 MAPK in AGS human gastric cancer cells
- (2012) Jaemoo Chun et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma
- (2012) Vladimir Ratushny et al. JOURNAL OF CLINICAL INVESTIGATION
- Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma
- (2011) Megumi Fujita et al. CANCER LETTERS
- Role of 5-lipoxygenase in resveratrol mediated suppression of 7,12-dimethylbenz(α)anthracene-induced mammary carcinogenesis in rats
- (2011) Mary Chatterjee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Treatment of giant Bowen's disease with sequential use of photodynamic therapy and imiquimod cream
- (2011) Eleni Sotiriou et al. PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE
- Photodynamic therapy (PDT) – Initiation of apoptosis via activation of stress-activated p38 MAPK and JNK signal pathway in H460 cell lines
- (2011) R.W.K. Wu et al. Photodiagnosis and Photodynamic Therapy
- Incidence Trends of Squamous Cell and Rare Skin Cancers in the Swedish National Cancer Registry Point to Calendar Year and Age-Dependent Increases
- (2010) Shehnaz K. Hussain et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment efficiency of combining photodynamic therapy and ionizing radiation for Bowen’s disease
- (2010) A Nakano et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started